Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism; D002715:Chlormadinone Acetate / Q000494:pharmacology; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004116:Dimethisterone / Q000494:pharmacology; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005040:Ethynodiol Diacetate / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood*; D007031:Hypothalamus / Q000187:drug effects*; D007986:Luteinizing Hormone / Q000097:blood*; D008234:Lynestrenol / Q000494:pharmacology; D008535:Megestrol / Q000494:pharmacology; D008656:Mestranol / Q000494:pharmacology; D009640:Norethindrone / Q000494:pharmacology; D009641:Norethynodrel / Q000494:pharmacology; D010053:Ovary / Q000378:metabolism; D010906:Pituitary Hormone-Releasing Hormones; D011278:Pregnanes / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology; D011863:Radioimmunoassay; D051381:Rats
D000731:Androstanes; D003276:Contraceptives, Oral; D010906:Pituitary Hormone-Releasing Hormones; D011278:Pregnanes; D011372:Progestins; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D005040:Ethynodiol Diacetate; D009641:Norethynodrel; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008656:Mestranol; D008535:Megestrol; D004116:Dimethisterone; D008234:Lynestrenol; D001205:Ascorbic Acid; D009640:Norethindrone